TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TOI

Oncology Institute Inc

Healthcare · Medical Care Facilities

6.20$ +20.9% vs. previous close Closing price · As of: Aug 11, 2026

Investor relations

Report Dates

Investor relations overview for Oncology Institute Inc (TOI): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/06/2026.

Next report 08/06/2026
Last report 05/07/2026
Earnings surprise by quarter (%)
Q2 23 · -11.8 % 23 Q3 23 · 146.2 % 23 Q4 23 · -90.9 % 23 Q1 24 · -58.3 % 24 Q2 24 · -40.0 % 24 Q3 24 · -191.8 % 24 Q4 24 · -78.8 % 24 Q2 25 · -25.0 % 25 Q3 25 · -27.3 % 25 Q4 25 · 29.7 % 25 Q1 26 · 77.8 % 26

EPS estimate beaten

Full history 4 of 16 quarters (25%)

Earnings Call Transcripts

Search all transcripts →

  • 05/08/2026 Earnings Call Q1 2026 Open →
  • 03/13/2026 Earnings Call Q4 2025 Open →
  • 11/13/2025 Earnings Call Q3 2025 Open →
  • 08/13/2025 Earnings Call Q2 2025 Open →
  • 05/14/2025 Earnings Call Q1 2025 Open →
  • 03/25/2025 Earnings Call Q4 2024 Open →
  • 11/13/2024 Earnings Call Q3 2024 Open →
  • 08/13/2024 Earnings Call Q2 2024 Open →
  • 05/14/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/21/2026 Starling Oncology, Inc. (TOI): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 Starling Oncology, Inc. (TOI): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/03/2026 Oncology Institute, Inc. (TOI): Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/07/2026 Oncology Institute, Inc. (TOI): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?